Aspirin Enhances the Cytotoxic Activity of Bortezomib Against Myeloma Cells via Suppression of BCL-2, Survivin and Phosphorylation of AKT
Oncology Letters - Greece
doi 10.3892/ol.2016.5472
Full Text
Open PDFAbstract
Available in full text
Date
December 8, 2016
Authors
Publisher
Spandidos Publications